Report Detail

Medical Devices & Consumables Global Tumor Mice Model Market Research Report 2022

  • RnM4438575
  • |
  • 11 May, 2022
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Table of Contents

    1 Tumor Mice Model Market Overview

    • 1.1 Product Overview and Scope of Tumor Mice Model
    • 1.2 Tumor Mice Model Segment by Type
      • 1.2.1 Global Tumor Mice Model Sales Growth Rate Comparison by Type (2022-2028)
      • 1.2.2 Humanized Immune System Mice Models
      • 1.2.3 Syngeneic Tumor Mice Models
      • 1.2.4 Immunodeficient Mice Models
      • 1.2.5 NOG Mice Models
      • 1.2.6 Spontaneous Tumor Mice Models
      • 1.2.7 Others
    • 1.3 Tumor Mice Model Segment by Application
      • 1.3.1 Global Tumor Mice Model Sales Comparison by Application: (2022-2028)
      • 1.3.2 Contract Research Organizations
      • 1.3.3 Pharma and Biopharma Companies
      • 1.3.4 Academic and Research Institutes
      • 1.3.5 Others
    • 1.4 Global Tumor Mice Model Market Size Estimates and Forecasts
      • 1.4.1 Global Tumor Mice Model Revenue 2017-2028
      • 1.4.2 Global Tumor Mice Model Sales 2017-2028
      • 1.4.3 Tumor Mice Model Market Size by Region: 2017 Versus 2021 Versus 2028

    2 Tumor Mice Model Market Competition by Manufacturers

    • 2.1 Global Tumor Mice Model Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Tumor Mice Model Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Tumor Mice Model Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Tumor Mice Model Manufacturing Sites, Area Served, Product Type
    • 2.5 Tumor Mice Model Market Competitive Situation and Trends
      • 2.5.1 Tumor Mice Model Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest Tumor Mice Model Players Market Share by Revenue
      • 2.5.3 Global Tumor Mice Model Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 Tumor Mice Model Retrospective Market Scenario by Region

    • 3.1 Global Tumor Mice Model Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Tumor Mice Model Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Tumor Mice Model Market Facts & Figures by Country
      • 3.3.1 North America Tumor Mice Model Sales by Country
      • 3.3.2 North America Tumor Mice Model Revenue by Country
      • 3.3.3 United States
      • 3.3.4 Canada
    • 3.4 Europe Tumor Mice Model Market Facts & Figures by Country
      • 3.4.1 Europe Tumor Mice Model Sales by Country
      • 3.4.2 Europe Tumor Mice Model Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Tumor Mice Model Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Tumor Mice Model Sales by Region
      • 3.5.2 Asia Pacific Tumor Mice Model Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 China Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
    • 3.6 Latin America Tumor Mice Model Market Facts & Figures by Country
      • 3.6.1 Latin America Tumor Mice Model Sales by Country
      • 3.6.2 Latin America Tumor Mice Model Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
      • 3.6.6 Colombia
    • 3.7 Middle East and Africa Tumor Mice Model Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Tumor Mice Model Sales by Country
      • 3.7.2 Middle East and Africa Tumor Mice Model Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Global Tumor Mice Model Historic Market Analysis by Type

    • 4.1 Global Tumor Mice Model Sales Market Share by Type (2017-2022)
    • 4.2 Global Tumor Mice Model Revenue Market Share by Type (2017-2022)
    • 4.3 Global Tumor Mice Model Price by Type (2017-2022)

    5 Global Tumor Mice Model Historic Market Analysis by Application

    • 5.1 Global Tumor Mice Model Sales Market Share by Application (2017-2022)
    • 5.2 Global Tumor Mice Model Revenue Market Share by Application (2017-2022)
    • 5.3 Global Tumor Mice Model Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 The Jackson Laboratory
      • 6.1.1 The Jackson Laboratory Corporation Information
      • 6.1.2 The Jackson Laboratory Description and Business Overview
      • 6.1.3 The Jackson Laboratory Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.1.4 The Jackson Laboratory Tumor Mice Model Product Portfolio
      • 6.1.5 The Jackson Laboratory Recent Developments/Updates
    • 6.2 Taconic Biosciences
      • 6.2.1 Taconic Biosciences Corporation Information
      • 6.2.2 Taconic Biosciences Description and Business Overview
      • 6.2.3 Taconic Biosciences Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.2.4 Taconic Biosciences Tumor Mice Model Product Portfolio
      • 6.2.5 Taconic Biosciences Recent Developments/Updates
    • 6.3 Charles River Laboratories
      • 6.3.1 Charles River Laboratories Corporation Information
      • 6.3.2 Charles River Laboratories Description and Business Overview
      • 6.3.3 Charles River Laboratories Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.3.4 Charles River Laboratories Tumor Mice Model Product Portfolio
      • 6.3.5 Charles River Laboratories Recent Developments/Updates
    • 6.4 Shanghai Model Organisms Center Inc.
      • 6.4.1 Shanghai Model Organisms Center Inc. Corporation Information
      • 6.4.2 Shanghai Model Organisms Center Inc. Description and Business Overview
      • 6.4.3 Shanghai Model Organisms Center Inc. Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Shanghai Model Organisms Center Inc. Tumor Mice Model Product Portfolio
      • 6.4.5 Shanghai Model Organisms Center Inc. Recent Developments/Updates
    • 6.5 Envigo
      • 6.5.1 Envigo Corporation Information
      • 6.5.2 Envigo Description and Business Overview
      • 6.5.3 Envigo Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.5.4 Envigo Tumor Mice Model Product Portfolio
      • 6.5.5 Envigo Recent Developments/Updates
    • 6.6 Biocytogen
      • 6.6.1 Biocytogen Corporation Information
      • 6.6.2 Biocytogen Description and Business Overview
      • 6.6.3 Biocytogen Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.6.4 Biocytogen Tumor Mice Model Product Portfolio
      • 6.6.5 Biocytogen Recent Developments/Updates
    • 6.7 Genoway
      • 6.6.1 Genoway Corporation Information
      • 6.6.2 Genoway Description and Business Overview
      • 6.6.3 Genoway Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Genoway Tumor Mice Model Product Portfolio
      • 6.7.5 Genoway Recent Developments/Updates
    • 6.8 Crown Bioscience Inc.
      • 6.8.1 Crown Bioscience Inc. Corporation Information
      • 6.8.2 Crown Bioscience Inc. Description and Business Overview
      • 6.8.3 Crown Bioscience Inc. Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.8.4 Crown Bioscience Inc. Tumor Mice Model Product Portfolio
      • 6.8.5 Crown Bioscience Inc. Recent Developments/Updates
    • 6.9 Cyagen
      • 6.9.1 Cyagen Corporation Information
      • 6.9.2 Cyagen Description and Business Overview
      • 6.9.3 Cyagen Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.9.4 Cyagen Tumor Mice Model Product Portfolio
      • 6.9.5 Cyagen Recent Developments/Updates
    • 6.10 Applied Stem Cells
      • 6.10.1 Applied Stem Cells Corporation Information
      • 6.10.2 Applied Stem Cells Description and Business Overview
      • 6.10.3 Applied Stem Cells Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.10.4 Applied Stem Cells Tumor Mice Model Product Portfolio
      • 6.10.5 Applied Stem Cells Recent Developments/Updates
    • 6.11 Ingenious Targeting Laboratory
      • 6.11.1 Ingenious Targeting Laboratory Corporation Information
      • 6.11.2 Ingenious Targeting Laboratory Tumor Mice Model Description and Business Overview
      • 6.11.3 Ingenious Targeting Laboratory Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.11.4 Ingenious Targeting Laboratory Tumor Mice Model Product Portfolio
      • 6.11.5 Ingenious Targeting Laboratory Recent Developments/Updates
    • 6.12 PolyGene-Transgenic mice model company
      • 6.12.1 PolyGene-Transgenic mice model company Corporation Information
      • 6.12.2 PolyGene-Transgenic mice model company Tumor Mice Model Description and Business Overview
      • 6.12.3 PolyGene-Transgenic mice model company Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.12.4 PolyGene-Transgenic mice model company Tumor Mice Model Product Portfolio
      • 6.12.5 PolyGene-Transgenic mice model company Recent Developments/Updates
    • 6.13 Creative Biolabs
      • 6.13.1 Creative Biolabs Corporation Information
      • 6.13.2 Creative Biolabs Tumor Mice Model Description and Business Overview
      • 6.13.3 Creative Biolabs Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.13.4 Creative Biolabs Tumor Mice Model Product Portfolio
      • 6.13.5 Creative Biolabs Recent Developments/Updates
    • 6.14 TransCure Bioservices
      • 6.14.1 TransCure Bioservices Corporation Information
      • 6.14.2 TransCure Bioservices Tumor Mice Model Description and Business Overview
      • 6.14.3 TransCure Bioservices Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.14.4 TransCure Bioservices Tumor Mice Model Product Portfolio
      • 6.14.5 TransCure Bioservices Recent Developments/Updates
    • 6.15 Champions Oncology Inc
      • 6.15.1 Champions Oncology Inc Corporation Information
      • 6.15.2 Champions Oncology Inc Tumor Mice Model Description and Business Overview
      • 6.15.3 Champions Oncology Inc Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.15.4 Champions Oncology Inc Tumor Mice Model Product Portfolio
      • 6.15.5 Champions Oncology Inc Recent Developments/Updates
    • 6.16 Certis Oncology
      • 6.16.1 Certis Oncology Corporation Information
      • 6.16.2 Certis Oncology Tumor Mice Model Description and Business Overview
      • 6.16.3 Certis Oncology Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.16.4 Certis Oncology Tumor Mice Model Product Portfolio
      • 6.16.5 Certis Oncology Recent Developments/Updates
    • 6.17 Signature
      • 6.17.1 Signature Corporation Information
      • 6.17.2 Signature Tumor Mice Model Description and Business Overview
      • 6.17.3 Signature Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.17.4 Signature Tumor Mice Model Product Portfolio
      • 6.17.5 Signature Recent Developments/Updates
    • 6.18 Pharmaron
      • 6.18.1 Pharmaron Corporation Information
      • 6.18.2 Pharmaron Tumor Mice Model Description and Business Overview
      • 6.18.3 Pharmaron Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.18.4 Pharmaron Tumor Mice Model Product Portfolio
      • 6.18.5 Pharmaron Recent Developments/Updates
    • 6.19 Laboratory Corporation of America Holdings
      • 6.19.1 Laboratory Corporation of America Holdings Corporation Information
      • 6.19.2 Laboratory Corporation of America Holdings Tumor Mice Model Description and Business Overview
      • 6.19.3 Laboratory Corporation of America Holdings Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.19.4 Laboratory Corporation of America Holdings Tumor Mice Model Product Portfolio
      • 6.19.5 Laboratory Corporation of America Holdings Recent Developments/Updates
    • 6.20 Gempharmatech
      • 6.20.1 Gempharmatech Corporation Information
      • 6.20.2 Gempharmatech Tumor Mice Model Description and Business Overview
      • 6.20.3 Gempharmatech Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.20.4 Gempharmatech Tumor Mice Model Product Portfolio
      • 6.20.5 Gempharmatech Recent Developments/Updates
    • 6.21 Janvier Labs
      • 6.21.1 Janvier Labs Corporation Information
      • 6.21.2 Janvier Labs Tumor Mice Model Description and Business Overview
      • 6.21.3 Janvier Labs Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.21.4 Janvier Labs Tumor Mice Model Product Portfolio
      • 6.21.5 Janvier Labs Recent Developments/Updates
    • 6.22 Harbour BioMed
      • 6.22.1 Harbour BioMed Corporation Information
      • 6.22.2 Harbour BioMed Tumor Mice Model Description and Business Overview
      • 6.22.3 Harbour BioMed Tumor Mice Model Sales, Revenue and Gross Margin (2017-2022)
      • 6.22.4 Harbour BioMed Tumor Mice Model Product Portfolio
      • 6.22.5 Harbour BioMed Recent Developments/Updates

    7 Tumor Mice Model Manufacturing Cost Analysis

    • 7.1 Tumor Mice Model Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Tumor Mice Model
    • 7.4 Tumor Mice Model Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Tumor Mice Model Distributors List
    • 8.3 Tumor Mice Model Customers

    9 Tumor Mice Model Market Dynamics

    • 9.1 Tumor Mice Model Industry Trends
    • 9.2 Tumor Mice Model Market Drivers
    • 9.3 Tumor Mice Model Market Challenges
    • 9.4 Tumor Mice Model Market Restraints

    10 Global Market Forecast

    • 10.1 Tumor Mice Model Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Tumor Mice Model by Type (2023-2028)
      • 10.1.2 Global Forecasted Revenue of Tumor Mice Model by Type (2023-2028)
    • 10.2 Tumor Mice Model Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Tumor Mice Model by Application (2023-2028)
      • 10.2.2 Global Forecasted Revenue of Tumor Mice Model by Application (2023-2028)
    • 10.3 Tumor Mice Model Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Tumor Mice Model by Region (2023-2028)
      • 10.3.2 Global Forecasted Revenue of Tumor Mice Model by Region (2023-2028)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:

      Syngeneic mice retain an intact immune system; therefore, they are specifically used in immune-oncology studies. Cancer immunotherapies are designed to work in conjunction with a patient’s immune system to increase natural anti-tumor response.Oncology Mice Models Market Segmented By Humanized Immune System Mice Models, Syngeneic Tumor Mice Models, Immunodeficient Mice Models, NOG Mice Models, Spontaneous Tumor Mice Models Product
      Industry Insights
      Due to the COVID-19 pandemic, the global Tumor Mice Model market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Tumor Mice Model market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Tumor Mice Model landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
      Humanized Immune System Mice Models accounting for % of the Tumor Mice Model global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Contract Research Organizations segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
      The global major manufacturers of Tumor Mice Model include The Jackson Laboratory, Taconic Biosciences, Charles River Laboratories, Shanghai Model Organisms Center Inc., Envigo, Biocytogen, Genoway, Crown Bioscience Inc. and Cyagen, etc. In terms of revenue, the global 3 largest players have a % market share of Tumor Mice Model in 2021.
      This report focuses on Tumor Mice Model volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Tumor Mice Model market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
      Key Drivers & Barriers
      High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
      Post-covid-19 Outlook
      The readers in the section will understand how the Tumor Mice Model market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
      Segmental Outlook
      Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
      Segment by Type
      Humanized Immune System Mice Models
      Syngeneic Tumor Mice Models
      Immunodeficient Mice Models
      NOG Mice Models
      Spontaneous Tumor Mice Models
      Others
      Segment by Application
      Contract Research Organizations
      Pharma and Biopharma Companies
      Academic and Research Institutes
      Others
      Regional Outlook
      This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Scenario
      In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
      The Jackson Laboratory
      Taconic Biosciences
      Charles River Laboratories
      Shanghai Model Organisms Center Inc.
      Envigo
      Biocytogen
      Genoway
      Crown Bioscience Inc.
      Cyagen
      Applied Stem Cells
      Ingenious Targeting Laboratory
      PolyGene-Transgenic mice model company
      Creative Biolabs
      TransCure Bioservices
      Champions Oncology Inc
      Certis Oncology
      Signature
      Pharmaron
      Laboratory Corporation of America Holdings
      Gempharmatech
      Janvier Labs
      Harbour BioMed
      Frequently Asked Questions
      Which product segment grabbed the largest share in the Tumor Mice Model market?
      How is the competitive scenario of the Tumor Mice Model market?
      Which are the key factors aiding the Tumor Mice Model market growth?
      Which are the prominent players in the Tumor Mice Model market?
      Which region holds the maximum share in the Tumor Mice Model market?
      What will be the CAGR of the Tumor Mice Model market during the forecast period?
      Which application segment emerged as the leading segment in the Tumor Mice Model market?
      What key trends are likely to emerge in the Tumor Mice Model market in the coming years?
      What will be the Tumor Mice Model market size by 2028?
      Which company held the largest share in the Tumor Mice Model market?


      Summary:
      Get latest Market Research Reports on Tumor Mice Model. Industry analysis & Market Report on Tumor Mice Model is a syndicated market report, published as Global Tumor Mice Model Market Research Report 2022. It is complete Research Study and Industry Analysis of Tumor Mice Model market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,328.70
      4,657.40
      2,746.30
      5,492.60
      370,446.00
      740,892.00
      224,576.00
      449,152.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report